Advanced Urothelial Carcinoma

Impact of Immune Checkpoint Inhibitors on Advanced Urothelial Carcinoma
Immune checkpoint inhibitors are becoming more common treatments for bladder cancer, with the US Food and Drug Administration (FDA) approving several drugs of this type for use in patients with advanced bladder cancer. Shilpa Gupta, MD, director of the Genitourinary Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute and co-leader of the Cleveland Clinic Genitourinary Oncology Program, discussed the impact of immune checkpoint inhibitors on care of patients with advanced bladder cancer. ...
Advertisement

Latest News

Advertisement

Urothelial Carcinoma Knowledge Hubs

Curated clinical content based on urothelial cancer types, therapies, and technologies

Urothelial Carcinoma
Urothelial Carcinoma

Conference Coverage

Advertisement
Advertisement
Trending